Centene 2024 Product Expansion From 2022. In terms of returning additional value to shareholders, share repurchases are expected to play a more meaningful role in 2022 and beyond. Beginning in january 2024, express scripts will manage pharmacy benefits for approximately 20 million centene members.
Centene corporation reports 2023 results. Premium and service revenues of $34.2 billion for the first quarter of 2022, representing 22% growth compared to the first quarter of 2021.
Cnc), Announced Today It Will Expand Its Wide Range Of Medicare.
The corporation reiterated its 2024 adjusted diluted eps guidance floor of greater than $6.70.
In Terms Of Returning Additional Value To Shareholders, Share Repurchases Are Expected To Play A More Meaningful Role In 2022 And Beyond.
For 2022, the company has increased its premium and service revenues guidance range by $2.0 billion to a new range of $134.3 billion to $136.3 billion and has.
2023 Adjusted Diluted Eps Of $6.68, Up Over 15% From $5.78 In 2022.
Images References :
Centene Updated The 2024 Adjusted Eps Target To Greater Than $6.60, Reflecting An Updated View Of Medicaid Redeterminations, Medicare Bid Strategy, And.
The company plans to expand into 327.
Increases 2024 Full Year Adjusted Diluted Eps Guidance By $0.10 To Greater Than $6.80.
Beginning in january 2024, express scripts will manage pharmacy benefits for approximately 20 million centene members.